Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (11)

1

Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy : A Multicenter Retrospective Study

enthalten in: Anticancer research | 2023

von Abe, M. | Shoji, T. | Chiba, Y. | +7

2

Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment : A Multicenter Retrospective Italian Study

enthalten in: Anticancer research | 2022

von Gadducci, A. | Cosio, S. | Landoni, F. | +6

3

Randomized Clinical Trials and Real World Prospective Observational Studies on Bevacizumab, PARP Inhibitors, and Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Ovarian Carcinoma : A Critical Review

enthalten in: Anticancer research | 2021

von Gadducci, A. | Cosio, S.

4

Treatment of Metastatic Castration-resistant Prostate Cancer : Are PARP Inhibitors Shifting the Paradigm?

enthalten in: Anticancer research | 2021

von Fujimoto, N. | Harada, K. | Shiota, M. | +6

5

PARP Inhibitors as Therapeutic Options for Tyrosine Kinase-dependent Leukemia : A Review

enthalten in: Anticancer research | 2020

von Machado, C. | DA Silva, E. | DE Moraes Filho, M. | +2

6

Olaparib Potentiates Anticancer Drug Cytotoxicity via 53BP1 in Oesophageal Squamous Cell Carcinoma Cells

enthalten in: Anticancer research | 2020

von Miyamoto, K. | Minegaki, T. | Hirano, S. | +3

7

Synergistic Effects of Olaparib and DNA-damaging Agents in Oesophageal Squamous Cell Carcinoma Cell Lines

enthalten in: Anticancer research | 2019

von Miyamoto, K. | Minegaki, T. | Tanahashi, M. | +9

8

PARP Inhibitors in Epithelial Ovarian Cancer : State of Art and Perspectives of Clinical Research

enthalten in: Anticancer research | 2016

von Gadducci, A. | Guerrieri, M.

9

Advanced epithelial ovarian cancer : from standard chemotherapy to promising molecular pathway targets--where are we now?

enthalten in: Anticancer research | 2014

von Syrios, J. | Banerjee, S. | Kaye, S.

10

Combinatorial effects of PARP inhibitor PJ34 and histone deacetylase inhibitor vorinostat on leukemia cell lines

enthalten in: Anticancer research | 2014

von Jasek, E. | Gajda, M. | Lis, G. | +2